Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0M4BZ
|
|||
Former ID |
DNC007887
|
|||
Drug Name |
2-(3-(naphthalen-2-yl)propanamido)benzoic acid
|
|||
Synonyms |
CHEMBL235740; SCHEMBL5623042; BDBM23518; Biaryl Anthranilide Analogue, 1b; TUCHRHOVXUFQLY-UHFFFAOYSA-N; 2-[3-(naphthalen-2-yl)propanamido]benzoic acid; 2-{[3-(2-naphthalenyl)propanoyl]amino}benzoic acid
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C20H17NO3
|
|||
Canonical SMILES |
C1=CC=C2C=C(C=CC2=C1)CCC(=O)NC3=CC=CC=C3C(=O)O
|
|||
InChI |
1S/C20H17NO3/c22-19(21-18-8-4-3-7-17(18)20(23)24)12-10-14-9-11-15-5-1-2-6-16(15)13-14/h1-9,11,13H,10,12H2,(H,21,22)(H,23,24)
|
|||
InChIKey |
TUCHRHOVXUFQLY-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Nicotinic acid receptor (HCAR2) | Target Info | Inhibitor | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | Molecular modeling aided design of nicotinic acid receptor GPR109A agonists. Bioorg Med Chem Lett. 2008 Sep 15;18(18):4963-7. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.